Agilent Opens Spectroscopy Technology Innovation Center
News Sep 02, 2013
Agilent Technologies Inc. has announced the opening of its Spectroscopy Technology Innovation Center in Mulgrave, Australia.
The $25 million center houses cutting-edge research and testing laboratories as well as customer demo and training facilities.
“The Spectroscopy Technology Innovation Center is Agilent’s next big leap in developing world-leading spectroscopy products,” said Mike McMullen, president of Agilent’s Chemical Analysis Group.
McMullen continued, “The open-plan areas for project teams have been designed to foster interaction and to help improve customer and field linkages. Most importantly, our time-to-market for new products will be improved as we pursue our goal of clear leadership in our chosen markets.”
Used by laboratories around the world, spectroscopy instruments such as Agilent’s industry-leading atomic absorption spectrometer are critical measurement tools in a variety of applications.
They play key roles in the food, environmental and pharmaceutical markets, measuring for quality and containments.
The facility, located within the Monash Technology Precinct, provides advanced communications technology to facilitate collaboration between Agilent divisions, key research partners and customers across the globe.
A key design concept of the Spectroscopy Technology Innovation Center is that it fosters integration and collaboration and celebrates the division’s history, culture and successes.
Working spaces provide the flexibility to accommodate changes in science and project types, while project hubs are designed to be the nerve center-helping to build high-performance teams of the future.
Catalyst Can Degrade Alzheimer's-Related Amyloid Peptide Under Near-Infrared LightNews
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer's disease (AD)-related amyloid-β peptide (Αβ) under near-infrared (NIR) light irradiation has been developed.READ MORE
Understanding 'Disease Mechanisms' of ALSNews
Researchers are making strides in understanding the disease mechanism of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. They recently found that ubiquitin eliminates droplets of Ubiquilin-2 (UBQLN2) in solution. The discovery is noteworthy because UBQLN2 is a protein-encoding gene, mutations to which cause ALS and various types of dementia.READ MORE
A New Class of GlassNews
Lightning and volcanos both produce glass, and humans have been making glass from silicon dioxide since prehistory. Industrialization brought us boron-based glasses, polymer glasses and metallic glasses, but now an international team of researchers has developed a new family of glass based on metals and organic compounds that stacks up to the original silica in glass-forming ability.READ MORE
Comments | 0 ADD COMMENT
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018